Skip to main content

Table 2 All PIVC characteristics during insertion

From: Occurrence and incidence rate of peripheral intravascular catheter-related phlebitis and complications in critically ill patients: a prospective cohort study (AMOR-VENUS study)

Variables

Total

n = 7118

Location of insertion

 ICU

3429/7115 (48.2%)

 ER

1310/7115 (18.4%)

 Others (ward, OR, outpatients)

2376/7115 (33.4%)

Inserted site (n,%)

 Upper arm

473/7097 (6.7%)

 Forearm

3986/7097 (56.2%)

 Elbow

355/7097 (5.0%)

 Wrist

286/7097 (4.0%)

 Hand

1514/7097 (21.3%)

 Lower leg

283/7097 (4.0%)

 Dorsal foot

169/7097 (2.4%)

 Others

31/7097 (0.4%)

Catheter material (n,%)

 PEU-Vialona

2120/7118 (29.8%)

 Polyurethane

1968/7118 (27.7%)

 Polyethylene

0/7118 (0%)

 Tetrafluoroethylene

2695/7118 (37.9%)

 Others

335/7118 (4.8%)

Catheter gauge (n,%)

 14G

10/7009 (0.1%)

 16G

386/7009 (5.5%)

 18G

595/7009 (8.5%)

 20G

2464/7009 (35.2%)

 22G

3432/7009 (49.0%)

 23G

1/7009 (0.01%)

 24G

121/7009 (1.7%)

Dressing (n,%)

 Chlorhexidine-impregnated dressing

1/7043 (0.01%)

 Sterile polyurethane dressing

6844/7043 (97.2%)

 Non-sterile polyurethane dressing

85/7043 (1.2%)

 Gauze dressing

2/7043 (0.03%)

 Tape dressing

111/7043 (1.6%)

Any infection during catheterization (n,%)

1267 (17.8%)

Duration of catheterization, median (IQR), hours

36.0 (19.0-71.0)

Removal in ICU (n, %)

3705/7103 (52.2%)

  1. ICU intensive care unit, IQR interquartile range, PIVC peripheral intravenous catheter, ER emergency room, OR operation room, aPEU-Vialon polyetherurethane without leachable additives